The Access Breast Coil appearing for the first time at the RSNA meeting has a multichannel phased-array architecture to enhance image quality of the breast, axillary tissue, and chest wall. The investigational device, which is being shown at the Confirma booth, has multiple receivers to power the phased-array coils, which may reduce MR imaging time, as well as a large field-of-view. It can support unilateral and bilateral imaging.
The Access Breast Coil appearing for the first time at the RSNA meeting has a multichannel phased-array architecture to enhance image quality of the breast, axillary tissue, and chest wall. The investigational device, which is being shown at the Confirma booth, has multiple receivers to power the phased-array coils, which may reduce MR imaging time, as well as a large field-of-view. It can support unilateral and bilateral imaging.
The new coil has been designed with diagnostics, intervention, and ergonomics in mind. As an open coil, it provides access to interventional procedures from cranial-caudal, lateral, and medial directions.
The Access is equipped with elements that stabilize the breast and guide needle positioning. Its interventional components can accommodate all needle gauge sizes and vacuum-assisted biopsy systems. An integrated lighting system illuminates the biopsy field.
To maximize patient comfort, the breast coil has positioning accessories that not only reduce pressure on the sternum but adjust to the patient during breast MR diagnostic studies and interventional procedures. The accessories include a headrest, armrest, and torso pad.
Confirma markets computer-aided detection systems. Its premier product for automatically processing MR breast images, CADstream, is being used clinically by more than 150 centers in the U.S.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Mammography Study: AI Facilitates Greater Accuracy and Longer Fixation Time on Suspicious Areas
July 8th 2025While noting no differences in sensitivity, specificity or reading time with adjunctive AI for mammography screening, the authors of a new study noted a 4 percent higher AUC and increased fixation time on lesion regions.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Contrast-Enhanced Mammography and High-Concentration ICM Dosing: What a New Study Reveals
June 16th 2025New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.